In the present study, we evaluated the ability of 18F-BMS to act as a PET ligand for the detection of hepatic MC-1 activity using mice fed a MCD diet to clarify the mitochondrial dysfunction in the early phase of NAFLD. Here, ATP7A is linked to metabolic dysfunction-associated steatotic liver disease.